ClearB is developing a therapeutic vaccine designed to redirect patients’ immune systems toward functional cure of hepatitis B.

The World Health Organisation defines hepatitis B as “a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.”